Cadrubin 50mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Epirubicin (50mg)
Overview Cadrubin 50mg Injection
Carubicin 50mg injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy regimens. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; misuse can lead to severe adverse reactions. Benefits may not be apparent for weeks or months; discontinue only under medical guidance. This medication reduces contraceptive efficacy; reliable birth control is recommended for both genders during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and rash. It lowers blood cell counts, increasing infection risk, which can be life-threatening. Regular blood tests monitoring blood cell counts, kidney, liver, and heart function are necessary. Inform your doctor of any liver or heart conditions, and all other medications you're taking, as interactions can affect Carubicin's efficacy. Disclose pregnancy or breastfeeding.
Uses of Cadrubin 50mg Injection
Malignancy
Major Benefits of Cadrubin 50mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cadrubin 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Cadrubin 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cadrubin 50mg Injection works:
Cadrubin 50mg Injection is a chemotherapeutic agent used in the treatment of breast cancer. Its mechanism of action involves inhibiting topoisomerase II, a crucial enzyme in DNA replication within breast cancer cells. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, ultimately suppressing tumor growth and inducing cancer cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cadrubin 50mg Injection and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Cadrubin 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Cadrubin 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Cadrubin 50mg Injection may induce adverse reactions impacting driving capabilities. Nausea and vomiting, potential side effects of Cadrubin 50mg Injection, may temporarily compromise driving ability.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Cadrubin 50mg Injection is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended. Patients exhibiting serum creatinine exceeding 5 mg/dL might benefit from a reduced dosage.
LiverCAUTION
Patients with hepatic impairment should receive Cadrubin 50mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Cadrubin 50mg Injection is contraindicated in individuals with severe liver dysfunction.
What if you forget to take Cadrubin 50mg Injection :
NA
Facts to Know About Cadrubin 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline-based drug |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Class | Cytotoxic alkaloids |
3,018 People bought this recently